A quasi-experimental study in BMC Pediatrics found that a multimodal educational intervention for pediatric oncologists was ...
Zilurgisertib reduced total HO lesion volume and improved clinician-assessed joint mobility; no zilurgisertib-treated patients developed new HO lesions - Mirum plans to submit an sNDA ...
A retrospective Guangzhou cohort links specific viral and bacterial co-infections with severe outcomes, longer ...
Reliability under pressure can be defined as remaining connected to your standards when demands rise ( McGuire, 2026 ). That ...
Mirum Pharmaceuticals, Inc. announced positive results from Cohort 2 of the pivotal PROGRESS study of ATEBRIOZ (zilurgisertib), an oral activin receptor-like kinase 2 inhibitor, in pediatric patients ...
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a leading rare disease company, today announced positive results from Cohort 2 of ...
The hospital system told families in August that it plans to close its PANDAS/PANS treatment program in January.
For those who have memorized knowledge of children's rights and development but are confused by the differences between ...
The mean peak exercise capacity of patients in the study was only 83.8% of the age- and sex-predicted capacity for Swedish adults.
Mirror Now on MSN
Bengaluru doctors report surge in pediatric eye issues post-pandemic
Ophthalmologists in Bengaluru are urging parents to prioritize regular eye exams as children now account for 30% of daily ...
Pharmacies are an emerging setting. In a claims analysis covering 2010 to 2017, pharmacists administered a small share of ...
He did, however, note that testing of this year’s predominant viral strain, H1N1, revealed that a mutation may make it more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results